COPD both a burden and a loss Patients with Chronic Obstructive Pulmonary Disease, or COPD, revealed that they perceive their disease seeing that both a burden they need to deal with and seeing that a loss they have experienced, according to recent in-home study conducted by GlaxoSmithKline.They measured all relevant payments made within 30 days of the treatment to fully capture any costs that may have resulted from postoperative problems and unforeseen hospitalizations. They assessed the degree to which hospital payments, professional services, and service payments vary by the ambulatory care setting in which a procedure is conducted. The authors found that 88 percent of the techniques examined were performed at an ambulatory medical center or physician office. Ambulatory surgical physician and centers offices were less expensive than hospitals for all but two of the methods. For example, average adjusted total obligations for urodynamic methods performed at ambulatory surgical centers were significantly less than a third of these done in hospitals. In comparison to hospitals, workplace based prostate biopsies were nearly 75 percent less costly.